The estimated Net Worth of Sharon E. Underberg is at least $4.55 million dollars as of 16 February 2024. Ms. Underberg owns over 483 units of Idexx Laboratories stock worth over $2,742,514 and over the last 10 years she sold IDXX stock worth over $0. In addition, she makes $1,809,230 as Corporate Vice President, General Counsel et and Corporate Secretary at Idexx Laboratories.
Sharon has made over 15 trades of the Idexx Laboratories stock since 2015, according to the Form 4 filled with the SEC. Most recently she exercised 483 units of IDXX stock worth $99,952 on 16 February 2024.
The largest trade she's ever made was exercising 35,251 units of Idexx Laboratories stock on 15 December 2018 worth over $17,282,155. On average, Sharon trades about 4,296 units every 178 days since 2015. As of 16 February 2024 she still owns at least 5,594 units of Idexx Laboratories stock.
You can see the complete history of Ms. Underberg stock trades at the bottom of the page.
Sharon E. Underberg serves as Corporate Vice President, General Counsel, and Corporate Secretary of the Company. Ms. Underberg has been Corporate Vice President, General Counsel and Corporate Secretary since March 2019. She leads IDEXX's legal, compliance and Corporate Secretary groups. Prior to joining IDEXX in February 2019, Ms. Underberg was a member of the Eastman Kodak Company legal team for over 29 years, where she held various senior leadership positions of increasing responsibility, including most recently serving as General Counsel, Secretary and Senior Vice President from January 2015 to January 2019, Deputy General Counsel and Vice President, Legal Department, from September 2014 to January 2015 and Assistant General Counsel and Vice President, Legal Department, from June 2006 to September 2014. Prior to joining Kodak, Ms. Underberg was an attorney in private practice. She received a bachelor's degree in political science from Brandeis University and a J.D. from the University of Pennsylvania School of Law.
As the Corporate Vice President, General Counsel et and Corporate Secretary of Idexx Laboratories, the total compensation of Sharon Underberg at Idexx Laboratories is $1,809,230. There are 5 executives at Idexx Laboratories getting paid more, with Jonathan Ayers having the highest compensation of $8,309,800.
Sharon Underberg is 58, she's been the Corporate Vice President, General Counsel et and Corporate Secretary of Idexx Laboratories since 2019. There are 10 older and 13 younger executives at Idexx Laboratories. The oldest executive at Idexx Laboratories, Inc. is M. Anne Szostak, 69, who is the Independent Director.
Sharon's mailing address filed with the SEC is ONE IDEXX DRIVE, , WESTBROOK, ME, 04092.
Over the last 21 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers et Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
Idexx Laboratories executives and other stock owners filed with the SEC include: